- B2B
- Growth StageExpanding market presence
- Website
- Location
- Company size
- 11-50 people
- Total raised
- $41.2M
- Company type
- Healthcare Technology
- Markets
Genetesis careers
Our flagship product, the CardioFlux Magnetocardiograph, is primed to be the most cost-effective solution to the global challenge of chest pain triage in the observation unit/emergency room. The technology is an imaging platform based on the concept of 45 years of research in magnetocardiography (MCG), in which the weak magnetic fields generated by the heart can be passively (without the use of any radiation or stress) measured.
Using our patented data science and visualization methods, we have developed an intuitive backend for both the ER physician and the cardiologist who would usually interpret stress test results when considering percutaneous coronary intervention. A scan can be completed at rest (as opposed to a stress test) in 60-90 seconds and requires very minimal training.
Using our patented data science and visualization methods, we have developed an intuitive backend for both the ER physician and the cardiologist who would usually interpret stress test results when considering percutaneous coronary intervention. A scan can be completed at rest (as opposed to a stress test) in 60-90 seconds and requires very minimal training.
Genetesis hasn't added any jobs yet
Get notified when Genetesis posts new jobs.
Manny Setegn
Co-founder & CTO @Genetesis. Previously studying Computer Science and Engineering and Economics at @Ohio State University.
Vineet Erasala
Working at @Genetesis • Studied at @Case Western Reserve University. Innovation through calculated risk, teamwork, and resourcefulness.
Peeyush Shrivastava
Co-Founder and CEO of Genetesis
Total raised
$41.2M
Funded over
4 rounds
Latest round
Series C (Oct 2022)
Comprehensive health insurance plan
401k retirement savings plan with employer match
Flexible remote policy
Unlimited pto / sick leave
Complimentary gym membership
EarnIn • Palo Alto • $142k – $231k • 4 weeks ago